Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Hybridon receives clearance to initiate further GEM-132 trials

April 8, 1997

Antibacterial mupirocin sulfamates from SmithKline Beecham

April 7, 1997

Novel antifungal discovered by Takara Shuzo

April 4, 1997

Cubist prepares inhibitors of isoleucyl-tRNA synthetase

April 4, 1997

Phase I/II results of MedImmune's MEDI-493 reported

April 3, 1997

IVAX's generic acyclovir tentatively approved

April 3, 1997

Stromectol available in U.S. for parasitic infections

April 3, 1997

Uriach discloses new antifungal agents

April 3, 1997

IntraBiotics/Synt:em to develop protegrin analogues

April 2, 1997

FDA tentatively approves generic acyclovir

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...